Nirogacestat is approved by the FDA for treating rare non-cancerous soft tissue sarcomas.

Published Date: 01 Dec 2023

The USA. s. For adult patients who need nirogacestat (Ogsiveo) due to their desmoid tumors progressing, the Food and Drug Administration has approved the tablets.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Nirogacestat is approved by the FDA for treating rare non-cancerous soft tissue sarcomas.

2.

Three-Drug Regimens Make Case for a Role in Untreated and Relapsed/Refractory CLL

3.

Transplantation Fails to Improve Survival in Mantle Cell Lymphoma

4.

WHO launches plan for free child cancer medicines

5.

Gene therapy and chemotherapy may be combined in novel ways to treat bone cancer.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot